Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Barium to InRule
Mandate

Vinge advises on the sale of Barium to InRule

September 01, 2021 M&A

Vinge has advised Nidoco AB and other shareholders in connection with the sale of Barium AB to InRule Technology, Inc.

Barium is a SaaS company which assists organisations and employees to improve efficiency and to future‑proof their working methods and processes by offering an innovative web service where smart IT support and applications can be created so that the operations can be followed up, maintained and easily improved.

Vinge’s team primarily consisted of Johan Winnerblad, Desirée Hagenfeldt, Anna Thoms, Gustav Persson, Amanda Steen, Nathalie Hughes, Christoffer Widström and Viktoria Owetz Leyva.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025